Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2003
IL-1 trap. Regeneron/NovartisCem Gabay
Nature Clinical Practice. Rheumatology|September 10, 2008
Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?Cem Gabay
Arthritis Research & Therapy|August 11, 2006
Interleukin-6 and chronic inflammationCem Gabay
Expert Opinion on Biological Therapy|February 19, 2002
Cytokine inhibitors in the treatment of rheumatoid arthritisCem Gabay
Revue Medicale Suisse|March 20, 2022
Thomas Hügle, Cem Gabay
Revue Medicale Suisse|May 2, 2009
[Radiculopathy due to lumbar disc herniation]Stéphane Genevay, Cem Gabay
Seminars in Immunopathology|April 30, 2017
Cardiovascular risk in patients with rheumatoid arthritisKim Lauper, Cem Gabay
Nature Reviews. Rheumatology|September 10, 2014
Inflammation: IL-36 has proinflammatory effects in skin but not in jointsDamien Dietrich, Cem Gabay
Revue Medicale Suisse|July 19, 2017
Cem Gabay, Alexander So
Revue Medicale Suisse|March 13, 2019
Cem Gabay, Thomas Hügle
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2003
IL-1 trap. Regeneron/NovartisCem Gabay
Nature Clinical Practice. Rheumatology|September 10, 2008
Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?Cem Gabay
Arthritis Research & Therapy|August 11, 2006
Interleukin-6 and chronic inflammationCem Gabay
Expert Opinion on Biological Therapy|February 19, 2002
Cytokine inhibitors in the treatment of rheumatoid arthritisCem Gabay
Revue Medicale Suisse|March 20, 2022
Thomas Hügle, Cem Gabay
Revue Medicale Suisse|May 2, 2009
[Radiculopathy due to lumbar disc herniation]Stéphane Genevay, Cem Gabay
Seminars in Immunopathology|April 30, 2017
Cardiovascular risk in patients with rheumatoid arthritisKim Lauper, Cem Gabay
Nature Reviews. Rheumatology|September 10, 2014
Inflammation: IL-36 has proinflammatory effects in skin but not in jointsDamien Dietrich, Cem Gabay
Revue Medicale Suisse|July 19, 2017
Cem Gabay, Alexander So
Revue Medicale Suisse|March 13, 2019
Cem Gabay, Thomas Hügle
Pageof 26